Laura A Knecht
Overview
Explore the profile of Laura A Knecht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramos E, Dayan C, Chatenoud L, Sumnik Z, Simmons K, Szypowska A, et al.
N Engl J Med
. 2023 Oct;
389(23):2151-2161.
PMID: 37861217
Background: Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3)...
2.
Herold K, Gitelman S, Gottlieb P, Knecht L, Raymond R, Ramos E
Diabetes Care
. 2023 Aug;
46(10):1848-1856.
PMID: 37607392
Objective: In November 2022, teplizumab-mzwv became the first drug approved to delay the onset of stage 3 type 1 diabetes in adults and children age ≥8 years with stage 2...
3.
Brown D, East H, Eilerman B, Gordon M, King E, Knecht L, et al.
Clin Diabetes Endocrinol
. 2020 Dec;
6(1):18.
PMID: 33292727
Background: While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the...